Precision Neuroscience Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
56
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$27.5M
- Investors
-
7
Precision Neuroscience General Information
Description
Developer of a brain-computer interface technology designed to provide effective treatments for patients suffering from neurological illnesses. The company's technology is designed to be minimally invasive, safely removable and capable of processing large amounts of data, enabling medical professionals to directly connect the human brain with artificial intelligence.
Contact Information
Website
www.precisionneuro.ioCorporate Office
- 54 West 21st Street
- Suite 301
- New York, NY 10010
- United States
Precision Neuroscience Timeline
Precision Neuroscience Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC (Series C) | 02-Apr-2024 | $27.5M | 0000 | Completed | Pre-Clinical Trials | |
2. Early Stage VC (Series B) | 25-Jan-2023 | 0000 | 0000 | 00000 | Completed | Pre-Clinical Trials |
1. Early Stage VC (Series A) | 25-May-2021 | $12M | $12M | 0000 | Completed | Pre-Clinical Trials |
Precision Neuroscience Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 000 | |
Series A | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00.000 |
Precision Neuroscience Comparisons
Industry
Financing
Details
Precision Neuroscience Competitors (9)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Neuralink | Venture Capital-Backed | Fremont, CA | 000 | 00000 | 00000000000 | 00000 |
Blackrock Neurotech | Venture Capital-Backed | Salt Lake City, UT | 000 | 000.00 | 000000000000 | 000.00 |
Synchron | Venture Capital-Backed | New York, NY | 000 | 00000 | 00000000000 | 00000 |
Kernel | Venture Capital-Backed | Los Angeles, CA | 00 | 000.00 | 0000000000 0 | 000.00 |
Paradromics | Venture Capital-Backed | Austin, TX | 00 | 000.00 | 00000000000 | 000.00 |
Precision Neuroscience Patents
Precision Neuroscience Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240134453-A1 | Data-efficient transfer learning for neural decoding applications | Pending | 24-Oct-2022 | 000000000 | |
US-20240130682-A1 | Secure interfaces for medical devices | Pending | 20-Oct-2022 | 0000000000 | |
US-20240131342-A1 | High-bandwidth systems for closed-loop deep brain stimulation | Pending | 20-Oct-2022 | 00000000000 | |
US-20240131335-A1 | High-bandwidth systems for closed-loop signal cord stimulation | Pending | 20-Oct-2022 | 00000000000 | |
US-20240137348-A1 | Secure interfaces for neural devices | Pending | 20-Oct-2022 | H04L63/0428 |
Precision Neuroscience Executive Team (7)
Precision Neuroscience Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
Benjamin Rapoport Ph.D | Precision Neuroscience | Co-founder, Chief Scientific Officer & Board Member | 000 0000 |
Craig Mermel | Precision Neuroscience | Chief Product Officer, President & Board Member | 000 0000 |
Eric Attias | Forepont Capital Partners | Board Member | 000 0000 |
Howard Morgan Ph.D | B Capital Group | Board Member | 000 0000 |
Jason Chen Ph.D | Self | Board Member | 000 0000 |
Precision Neuroscience Signals
Precision Neuroscience Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Alumni Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Draper Associates | Venture Capital | Minority | 000 0000 | 000000 0 | |
Forepont Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Mubadala Capital | Asset Manager | Minority | 000 0000 | 000000 0 | |
re.Mind Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
Precision Neuroscience Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Precision Neuroscience (Manufacturing Facility in Dallas, Texas) | 05-Oct-2023 | 000000000 | Buildings and Property | 0000000 0 |
Precision Neuroscience FAQs
-
When was Precision Neuroscience founded?
Precision Neuroscience was founded in 2021.
-
Who is the founder of Precision Neuroscience?
Benjamin Rapoport Ph.D, Mark Hettick Ph.D, Demetrios Papageorgiou Ph.D, and Michael Mager are the founders of Precision Neuroscience.
-
Who is the CEO of Precision Neuroscience?
Michael Mager is the CEO of Precision Neuroscience.
-
Where is Precision Neuroscience headquartered?
Precision Neuroscience is headquartered in New York, NY.
-
What is the size of Precision Neuroscience?
Precision Neuroscience has 56 total employees.
-
What industry is Precision Neuroscience in?
Precision Neuroscience’s primary industry is Therapeutic Devices.
-
Is Precision Neuroscience a private or public company?
Precision Neuroscience is a Private company.
-
What is Precision Neuroscience’s current revenue?
The current revenue for Precision Neuroscience is 000000.
-
How much funding has Precision Neuroscience raised over time?
Precision Neuroscience has raised $53M.
-
Who are Precision Neuroscience’s investors?
Alumni Ventures, Draper Associates, Forepont Capital Partners, Mubadala Capital, and re.Mind Capital are 5 of 7 investors who have invested in Precision Neuroscience.
-
Who are Precision Neuroscience’s competitors?
Neuralink, Blackrock Neurotech, Synchron, Kernel, and Paradromics are some of the 9 competitors of Precision Neuroscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »